Gastric or Gastroesophageal Junction Adenocarcinoma trials recruiting in Colorado

Fewer than 3 recruiting trials found.

All Gastric or Gastroesophageal Junction Adenocarcinoma trials nationally

1

Recruiting in Colorado

1

Cities with sites

Cities in Colorado

Denver 1

Recruiting trials in Colorado

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
NCT05482893 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Denver

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.